https://orcid.org/0000-0001-5089-8304
Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Amaravadhi Harikishore, Vikneswaran Mathiyazakan, Kevin Pethe & Gerhard Grüber. (2023) Novel targets and inhibitors of the Mycobacterium tuberculosis cytochrome bd oxidase to foster anti-tuberculosis drug discovery. Expert Opinion on Drug Discovery 18:8, pages 917-927.
Read now
Read now
Shasank S. Swain, Sunil S. Rout, Alaka Sahoo, Sunday O. Oyedemi & Tahziba Hussain. (2022) Antituberculosis, antioxidant and cytotoxicity profiles of quercetin: a systematic and cost-effective in silico and in vitro approach. Natural Product Research 36:18, pages 4757-4761.
Read now
Read now
Ma-chao Li, Jie Lu, Yao Lu, Tong-yang Xiao, Hai-can Liu, Shi-qiang Lin, Da Xu, Gui-lian Li, Xiu-qin Zhao, Zhi-guang Liu, Li-li Zhao & Kang-lin Wan. (2021) rpoB Mutations and Effects on Rifampin Resistance in Mycobacterium tuberculosis. Infection and Drug Resistance 14, pages 4119-4128.
Read now
Read now
Wubet Birhan Yigzaw, Jordi B Torrelles, Shu-Hua Wang & Belay Tessema. (2021) Magnitude of Phenotypic and MTBDRplus Line Probe Assay First-Line Anti-Tuberculosis Drug Resistance Among Tuberculosis Patients; Northwest Ethiopia. Infection and Drug Resistance 14, pages 497-505.
Read now
Read now
Articles from other publishers (28)
Adelina-Gabriela Niculescu, Georgiana Ramona Mük, Speranta Avram, Ilinca Margareta Vlad, Carmen Limban, Diana Nuta, Alexandru Mihai Grumezescu & Mariana-Carmen Chifiriuc. (2024) Novel strategies based on natural products and synthetic derivatives to overcome resistance in Mycobacterium tuberculosis. European Journal of Medicinal Chemistry 269, pages 116268.
Crossref
Crossref
Gaihua Cao, Nannan Yang, Yifan Xiong, Meimei Shi, Lin Wang, Fuping Nie, Danqun Huo & Changjun Hou. (2023) Completely Free from PAM Limitations: Asymmetric RPA with CRISPR/Cas12a for Nucleic Acid Assays. ACS Sensors 8:12, pages 4655-4663.
Crossref
Crossref
Simpal Kumar Suman, Natarajan Chandrasekaran & C. George Priya Doss. (2023) Micro-nanoemulsion and nanoparticle-assisted drug delivery against drug-resistant tuberculosis: recent developments. Clinical Microbiology Reviews 36:4.
Crossref
Crossref
Ankit Verma, Bindu Naik, Vijay Kumar, Sadhna Mishra, Megha Choudhary, Javed Masood Khan, Arun Kumar Gupta, Piyush Pandey, Sarvesh Rustagi, Barnali Kakati & Sanjay Gupta. (2023)
Revolutionizing Tuberculosis Treatment: Uncovering New Drugs and Breakthrough Inhibitors to Combat Drug-Resistant
Mycobacterium tuberculosis
. ACS Infectious Diseases 9:12, pages 2369-2385.
Crossref
Crossref
K. A. Ajin, Sethu Arun Kumar, Manisha Singh, H. S. Akshatha, Meduri Bhagyalalitha, Karthik G. Pujar, M. N. Sumana, V. M. Chandrashekar, Durgesh Bidye & Gurubasavaraj Veeranna Pujar. (2023) Novel Antitubercular Agents: Design, Synthesis, Molecular Dynamic and Biological Studies of Pyrazole – 1,2,4‐Triazole Conjugates. Chemistry & Biodiversity 20:11.
Crossref
Crossref
Archana Pant, Bhabatosh Das & Gopalakrishnan Aneeshkumar Arimbasseri. (2023) Host microbiome in tuberculosis: disease, treatment, and immunity perspectives. Frontiers in Microbiology 14.
Crossref
Crossref
Giuseppe Mancuso, Angelina Midiri, Silvia De Gaetano, Elena Ponzo & Carmelo Biondo. (2023) Tackling Drug-Resistant Tuberculosis: New Challenges from the Old Pathogen Mycobacterium tuberculosis. Microorganisms 11:9, pages 2277.
Crossref
Crossref
Jasmine Arya, Sweety Dahiya & Anil Kumar Chhillar. (2023) Multidrug-resistant Tuberculosis and its Implication with COVID-19. Coronaviruses 4:3.
Crossref
Crossref
A. V. Kukurika, E. I. Veselova & A. B. Peregudova. (2023) Genetic Aspects of Mycobacterium Tuberculosis Resistance to New Anti-Tuberculosis Drugs. Tuberculosis and Lung Diseases 101:4, pages 87-93.
Crossref
Crossref
Se-Mi Jeon, Sanghee Park, Na-Ra Lim, Noori Lee, Jihee Jung, Nackmoon Sung & Seonghan Kim. (2023) Molecular Analysis of Anti-Tuberculosis Drug Resistance of Mycobacterium tuberculosis Isolated in the Republic of Korea. Antibiotics 12:8, pages 1324.
Crossref
Crossref
Ebtisam S.A. Hassanin, Aliae AR. Mohamed Hussein, Shaimaa S. Abdelrheem, Ebtehal Dongol, Ahmed Hamdy Ahmed Mhsb, Asmaa M. Zahran, Mohamed Zein & Islam G. Sayed. (2023) Frequency of rifampicin-resistant mycobacterium tuberculosis by GeneXpert MTB/RIF assay and its correlates among 2605 probable tuberculosis patients in upper Egypt. Indian Journal of Tuberculosis 70:3, pages 345-355.
Crossref
Crossref
Saba Kabir, Hasan Ejaz, Syed Zajif Hussain, Muhammad Asif Rasheed, Kashaf Junaid & Abdul Rehman. (2023) Effect of tellurite on growth of extensively drug resistant (XDR) Mycobacterium tuberculosis and action on mycobacterial drug efflux pump. Journal of King Saud University - Science 35:4, pages 102629.
Crossref
Crossref
Yu-Xin Xiao, Kuang-Hung Liu, Wan-Hsuan Lin, Tai-Hua Chan & Ruwen Jou. (2023) Whole-genome sequencing-based analyses of drug-resistant Mycobacterium tuberculosis from Taiwan. Scientific Reports 13:1.
Crossref
Crossref
Usharani Brammachary, Venkateswari Ramachandra, Suganthi Palavesam, Vidya Raj Cuppusamy Kapalamurthy, Aaina Muralidhar & Muthuraj Muthaiah. 2023. Antibiotic Resistance - New Insights [Working Title]. Antibiotic Resistance - New Insights [Working Title].
Gaihua Cao, Yue Qiu, Keyi Long, Yi Ma, Huibo Luo, Mei Yang, Jingzhou Hou, Danqun Huo & Changjun Hou. (2022)
Rapid and Ultrasensitive Approach for the Simultaneous Detection of Multilocus Mutations to Distinguish Rifampicin-Resistant
Mycobacterium tuberculosis
. Analytical Chemistry 94:50, pages 17653-17661.
Crossref
Crossref
Wei Qu, Yinhui Guo, Yan Xu, Jie Zhang, Zongchao Wang, Chaoyue Ding & Yuanhu Pan. (2022) Advance in strategies to build efficient vaccines against tuberculosis. Frontiers in Veterinary Science 9.
Crossref
Crossref
Bashir A. Sheikh, Basharat A. Bhat, Zahoor Ahmad & Manzoor A. Mir. (2022) Strategies Employed to Evade the Host Immune Response and the Mechanism of Drug Resistance in Mycobacterium tuberculosis: In Search of Finding New Targets. Current Pharmaceutical Biotechnology 23:14, pages 1704-1720.
Crossref
Crossref
Kali Prasad Pattanaik, Srabasti Sengupta, Bimal Prasad Jit, Riddhi Kotak & Avinash Sonawane. (2022) Host-mycobacteria conflict: Immune responses of the host vs. the mycobacteria TLR2 and TLR4 ligands and concomitant host-directed therapy. Microbiological Research 264, pages 127153.
Crossref
Crossref
Shasank S. Swain & Tahziba Hussain. (2022) Combined Bioinformatics and Combinatorial Chemistry Tools to Locate Drug‐Able Anti‐TB Phytochemicals: A Cost‐Effective Platform for Natural Product‐Based Drug Discovery. Chemistry & Biodiversity 19:11.
Crossref
Crossref
David Kajoba Mumena, Geoffrey Kwenda, Caroline Wangari Ngugi & Andrew Kimang’a Nyerere. (2022) Drug-target genes and their spontaneous mutations associated with resistance to first-line, second-line, third-line, novel and repurposed anti-tuberculosis drugs in Mycobacterium tuberculosis resistant strains. IP International Journal of Medical Microbiology and Tropical Diseases 8:3, pages 196-204.
Crossref
Crossref
Bing‐Kang Sun, Rui‐Yu Wang, Bei Li, Xing Fan, Yuan Zhou, Bing Gu & Yang‐Yang Yan. (2022)
Rapid Identification of Polypeptide from Carbapenem‐Resistant and Susceptible
Escherichia coli
via Orbitrap‐MS and Pattern Recognition Analyses
. Chemistry & Biodiversity 19:9.
Crossref
Crossref
Aynias Seid, Nega Berhane & Semira Nureddin. (2022) Frequency of rpoB, katG, and inhA Gene Polymorphisms Associated with Multidrug-Resistant Mycobacterium tuberculosis Complex Isolates among Ethiopian TB Patients: A Systematic Review. Interdisciplinary Perspectives on Infectious Diseases 2022, pages 1-9.
Crossref
Crossref
Shasank S. Swain, Sanghamitra Pati & Tahziba Hussain. (2022) Quinoline heterocyclic containing plant and marine candidates against drug-resistant Mycobacterium tuberculosis: A systematic drug-ability investigation. European Journal of Medicinal Chemistry 232, pages 114173.
Crossref
Crossref
Timo Buhl & Michael P. Schön. 2022. Braun-Falco´s Dermatology. Braun-Falco´s Dermatology
221
245
.
Noor ul Ain Zahra, Faiza Jamil & Reaz Uddin. (2021) Protein Integrated Network Analysis to Reveal Potential Drug Targets Against Extended Drug-Resistant Mycobacterium tuberculosis XDR1219. Molecular Biotechnology 63:12, pages 1252-1267.
Crossref
Crossref
Anna Allué-Guardia, Juan I. García & Jordi B. Torrelles. (2021) Evolution of Drug-Resistant Mycobacterium tuberculosis Strains and Their Adaptation to the Human Lung Environment. Frontiers in Microbiology 12.
Crossref
Crossref
Timo Buhl & Michael P. Schön. 2020. Braun-Falco´s Dermatology. Braun-Falco´s Dermatology
1
26
.
Li-Yin Lai, Li-Yu Hsu, Shang-Hui Weng, Shuo-En Chung, Hui-En Ke, Tzu-Lung Lin, Pei-Fang Hsieh, Wei-Ting Lee, Hsing-Yuan Tsai, Wan-Hsuan Lin, Ruwen Jou & Jin-Town Wang. (2020) A Glutamine Insertion at Codon 432 of RpoB Confers Rifampicin Resistance in Mycobacterium tuberculosis. Frontiers in Microbiology 11.
Crossref
Crossref